Dr Reddy’s Arm To Buy Haleon Plc’s NRT Business, Including Nicotinell

HYDERABAD: Pharma major Dr Reddy’s Laboratories is acquiring British consumer healthcare player Haleon Plc’s entire nicotine replacement therapy (NRT) business, outside of the United States market, for a consideration of GBP 500 million.

As part of the deal, Dr Reddy’s arm Dr Reddy’s Laboratories SA will be acquiring 100% stake in newly incorporated Haleon group company Northstar Switzerland SARL and has inked a definitive agreement for the same, it said in a regulatory filing.

The portfolio being acquired by the Hyderabad-based company includes Nicotinell, touted as the second biggest brand in the NRT space globally with a footprint in 31 countries across Europe, Latin America and Asia, including countries like Japan. Nicotinell is also branded as Nicabate in Australia, Thrive in Canada and Habitrol in New Zealand and Canada.

The deal includes an upfront payment of GBP 458 million as well as performance-based contingent payments of up to GBP 42 million that will be payable in 2025 and 2026.

Dr Reddy’s said the deal, which is expected to close in the fourth quarter of 2024 and is subject to satisfactory completion of customary conditions, including regulatory approvals, will give it access to a global OTC anchor brand that would be a potential vehicle for the company to to build its global consumer healthcare OTC business.

“The proposed acquisition will be inclusive of all formats such as lozenge, patch, gum as well as pipeline products in all the applicable global markets outside of the US,” Dr Reddy’s said.

The total revenue of the portfolio being acquired clocked net revenues of around 217 million pounds in 2023. The company has been stepping up its presence in the consumer healthcare markets globally, acquiring several brands such as Habitrol in the NRT space, pain relief brand Doan’s, women’s health products like Premama for fertility and parenthood, and MenoLabs portfolio for menopause.

“The intellectual property, business contracts, dossiers and other assets related to the portfolio being acquired will reside in Northstar Switzerland and its fully owned step-down subsidiaries North Star OpCo Ltd and North Star Sweden AB, to be incorporated in England and Wales and Sweden, respectively,” it said.

Related Posts

  • Pharma
  • July 13, 2024
  • 117 views
Telangana DCA Seizes Overpriced Anti-Cancer Medicine In Karimnagar

Hyderabad: Drugs Control Administration officials seized ‘Dacazee 500 Injection’ (Dacarbazine Injection IP 500 mg), during the raids carried out on 11th and 12th July, 2024, at a medical shop located in…

  • Pharma
  • July 13, 2024
  • 84 views
Drug Price Regulation Leads To Decline In Availability Of Essential Medicines, Study Finds

Kolkata: The Drug Price Control Order (DPCO) 2013, India’s key drug regulation aimed at making essential medicines more affordable, has inadvertently led to a decline in the availability of these…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Telangana DCA Seizes Overpriced Anti-Cancer Medicine In Karimnagar

Telangana DCA Seizes Overpriced Anti-Cancer Medicine In Karimnagar

Drug Price Regulation Leads To Decline In Availability Of Essential Medicines, Study Finds

Drug Price Regulation Leads To Decline In Availability Of Essential Medicines, Study Finds

EMA Warns Of Anaphylactic Reactions To MS Drug

EMA Warns Of Anaphylactic Reactions To MS Drug

14 Barred Patanjali Products Sold Across Counter At Dedicated Stores

14 Barred Patanjali Products Sold Across Counter At Dedicated Stores

Mumbai: FDA Conducts Raids At Three Different Locations In Vasai, Seized Ayurvedic Drugs Worth Rs 1.41 Crore

Mumbai: FDA Conducts Raids At Three Different Locations In Vasai, Seized Ayurvedic Drugs Worth Rs 1.41 Crore

Telangana DCA Raids 2 Places, Seizes Illegally Stocked And Overpriced Medicines

Telangana DCA Raids 2 Places, Seizes Illegally Stocked And Overpriced Medicines